Wenshi Wei

1.4k total citations
54 papers, 1.0k citations indexed

About

Wenshi Wei is a scholar working on Neurology, Molecular Biology and Neurology. According to data from OpenAlex, Wenshi Wei has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 14 papers in Molecular Biology and 11 papers in Neurology. Recurrent topics in Wenshi Wei's work include Neuroinflammation and Neurodegeneration Mechanisms (11 papers), Neurological Disease Mechanisms and Treatments (10 papers) and Dementia and Cognitive Impairment Research (10 papers). Wenshi Wei is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (11 papers), Neurological Disease Mechanisms and Treatments (10 papers) and Dementia and Cognitive Impairment Research (10 papers). Wenshi Wei collaborates with scholars based in China, Japan and New Zealand. Wenshi Wei's co-authors include Zhen Hong, Li Zhang, Xiaoou Li, Xiaoyan Yang, Xun Chen, Z. Wang, Qiang Qiang, Aijuan Yan, Lu Yang and Jun Shen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Neurochemistry.

In The Last Decade

Wenshi Wei

49 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenshi Wei China 19 383 257 226 145 140 54 1.0k
Hang Guo China 21 500 1.3× 203 0.8× 227 1.0× 50 0.3× 94 0.7× 58 1.2k
Heng Zhao China 20 405 1.1× 141 0.5× 213 0.9× 44 0.3× 107 0.8× 76 1.5k
Hong Zhou China 19 318 0.8× 99 0.4× 169 0.7× 209 1.4× 256 1.8× 64 1.2k
Shih-Ying Wu Taiwan 21 692 1.8× 432 1.7× 309 1.4× 68 0.5× 198 1.4× 48 1.7k
Zhili Chen China 15 261 0.7× 92 0.4× 185 0.8× 302 2.1× 99 0.7× 65 1.2k
Huimin Chen China 22 287 0.7× 164 0.6× 143 0.6× 215 1.5× 124 0.9× 90 1.4k
Andreas Bartsch Germany 13 337 0.9× 227 0.9× 119 0.5× 345 2.4× 96 0.7× 27 1.5k
Song Cao China 18 230 0.6× 99 0.4× 98 0.4× 139 1.0× 297 2.1× 65 931
Qiang Gao China 23 274 0.7× 83 0.3× 353 1.6× 183 1.3× 71 0.5× 76 1.3k
Farzaneh Rahmani Iran 18 261 0.7× 69 0.3× 156 0.7× 215 1.5× 244 1.7× 75 1.2k

Countries citing papers authored by Wenshi Wei

Since Specialization
Citations

This map shows the geographic impact of Wenshi Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenshi Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenshi Wei more than expected).

Fields of papers citing papers by Wenshi Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenshi Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenshi Wei. The network helps show where Wenshi Wei may publish in the future.

Co-authorship network of co-authors of Wenshi Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Wenshi Wei. A scholar is included among the top collaborators of Wenshi Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenshi Wei. Wenshi Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mengqi, Zhang, et al.. (2025). DHCR24 deficiency causes AD-like pathology and cognitive decline via the cGAS-STING signaling pathway. Brain Behavior and Immunity. 131. 106150–106150.
2.
Wei, Wenshi, et al.. (2025). Spermidine Inhibits M1 Microglia Polarization in a Mouse Model of Parkinson's Disease and BV2 Cells via NF‐κB/STAT‐1 Pathway. Brain and Behavior. 15(3). e70410–e70410. 2 indexed citations
4.
Liu, Zhengxin, et al.. (2024). The association between precuneus cortex thickness and mild behavioral impairment in patients with mild stroke. Brain Imaging and Behavior. 19(1). 99–110.
5.
Qiang, Qiang, Loren Skudder‐Hill, Tomoko Toyota, et al.. (2024). CSF 14–3-3 zeta(ζ) isoform is associated with tau pathology and cognitive decline in Alzheimer's disease. Journal of the Neurological Sciences. 457. 122861–122861. 4 indexed citations
6.
Li, Nan, Xiaojun Wang, Fuxia Yang, et al.. (2024). ANGPTL4-mediated microglial lipid droplet accumulation: Bridging Alzheimer's disease and obesity. Neurobiology of Disease. 203. 106741–106741. 3 indexed citations
7.
Shen, Jun, et al.. (2023). Association between White Matter Hyperintensities Burden and Cognitive Function in Adult Asymptomatic Moyamoya Disease. Journal of Clinical Medicine. 12(3). 1143–1143. 4 indexed citations
8.
Yang, Fuxia, et al.. (2023). White matter hyperintensity mediating gait disorders in iNPH patients via neurofilament light chain. Frontiers in Aging Neuroscience. 15. 1117675–1117675. 3 indexed citations
9.
Zhang, Hanwen, Guidong Liu, Li Zhang, & Wenshi Wei. (2023). Personalized Biomarkers and Neuropsychological Status Can Predict Post-Stroke Fatigue. Brain Sciences. 13(2). 295–295. 8 indexed citations
11.
Shu, Jun, et al.. (2022). Association Between Stroke Characteristics and Post-Stroke Fatigue. Neurology India. 70(2). 676–681. 2 indexed citations
12.
Shu, Jun, et al.. (2022). Exosomes Derived From M2 Microglia Cells Attenuates Neuronal Impairment and Mitochondrial Dysfunction in Alzheimer’s Disease Through the PINK1/Parkin Pathway. Frontiers in Cellular Neuroscience. 16. 874102–874102. 43 indexed citations
13.
Shu, Jun, Wenshi Wei, & Li Zhang. (2022). Identification of Molecular Signatures and Candidate Drugs in Vascular Dementia by Bioinformatics Analyses. Frontiers in Molecular Neuroscience. 15. 751044–751044. 15 indexed citations
14.
Lu, Yang, et al.. (2022). Identification of programmed cell death-related gene signature and associated regulatory axis in cerebral ischemia/reperfusion injury. Frontiers in Genetics. 13. 934154–934154. 21 indexed citations
15.
Zhang, Li, et al.. (2018). MicroRNA-26b Regulates the Microglial Inflammatory Response in Hypoxia/Ischemia and Affects the Development of Vascular Cognitive Impairment. Frontiers in Cellular Neuroscience. 12. 154–154. 34 indexed citations
16.
Lv, Qing, et al.. (2018). Deep Brain Stimulation: A Potential Treatment for Dementia in Alzheimer's Disease (AD) and Parkinson's Disease Dementia (PDD). Frontiers in Neuroscience. 12. 360–360. 35 indexed citations
17.
Liu, Guidong, Jie Chang, Zhijun Liu, et al.. (2014). Chorea disclosing a polycythemia vera. Neuropsychiatric Disease and Treatment. 10. 563–563. 4 indexed citations
18.
Lü, Lei, Wenshi Wei, Yunyi Hong, et al.. (2014). Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson’s disease. Experimental and Therapeutic Medicine. 8(3). 943–950. 45 indexed citations
19.
Li, Xiaoou, et al.. (2013). Identifying Patients with Poststroke Mild Cognitive Impairment by Pattern Recognition of Working Memory Load-Related ERP. Computational and Mathematical Methods in Medicine. 2013. 1–10. 21 indexed citations
20.
Hong, Zhen, et al.. (2012). The microRNA miR-181c controls microglia-mediated neuronal apoptosis by suppressing tumor necrosis factor. Journal of Neuroinflammation. 9(1). 211–211. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026